The development of nanoparticles for the detection and imaging of ovarian cancers

Edward Henderson, Gabriel Huynh, Kirsty Wilson, Magdalena Plebanski, Simon R. Corrie

Research output: Contribution to journalReview ArticleOtherpeer-review

7 Citations (Scopus)

Abstract

Ovarian cancer remains as one of the most lethal gynecological cancers to date, with major challenges associated with screening, diagnosis and treatment of the disease and an urgent need for new technologies that can meet these challenges. Nanomaterials provide new opportunities in diagnosis and therapeutic management of many different types of cancers. In this review, we highlight recent promising developments of nanoparticles designed specifically for the detection or imaging of ovarian cancer that have reached the preclinical stage of development. This includes contrast agents, molecular imaging agents and intraoperative aids that have been designed for integration into standard imaging procedures. While numerous nanoparticle systems have been developed for ovarian cancer detection and imaging, specific design criteria governing nanomaterial targeting, biodistribution and clearance from the peritoneal cavity remain key challenges that need to be overcome before these promising tools can accomplish significant breakthroughs into the clinical setting.

Original languageEnglish
Article number1554
Number of pages26
JournalBiomedicines
Volume9
Issue number11
DOIs
Publication statusPublished - 28 Oct 2021

Keywords

  • Contrast agents
  • Imaging
  • Intraoperative aids
  • Molecular imaging
  • Nanoparticles
  • Nanotechnology
  • Ovarian cancer

Cite this